Vimal Mehta Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity
Vimal Mehta is CEO and President of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 4,486 shares of BTAI, which is worth approximately $7,850. The most recent transaction as insider was on Mar 21, 2023, when has been sold 30,000 shares (Common Stock) at a price of $19.93 per share, resulting in proceeds of $597,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.49K
9.31%
3M change
90.56%
12M change
Total Value Held
$7,850
Vimal Mehta Transaction History
VM
Vimal Mehta
CEO and President
New Haven, CT